Pak1 Agonists and Methods of Use

The present invention is directed to Pak1 agonists and methods of use.

Patents:
WO 2,010,017,478   [MORE INFO]

Inventor(s): KE YUNBO [US]; SOLARO ROSS JOHN [US]

Type of Offer: Licensing



« More Biotech Patents

---